中国实用神经疾病杂志
中國實用神經疾病雜誌
중국실용신경질병잡지
CHINESE JOURNAL OF PRACTICAL NERVOUS DISEASES
2014年
17期
43-44,45
,共3页
脑出血%依达拉奉%炎性细胞因子
腦齣血%依達拉奉%炎性細胞因子
뇌출혈%의체랍봉%염성세포인자
Cerebral hemorrhage%Edaravone%Inflammatory cytokines
目的:研究依达拉奉对急性脑出血患者炎性细胞因子水平及神经功能的影响。方法68例脑出血患者随机均分为实验组和对照组,对照组采用常规脱水药、抗生素等治疗,实验组在对照组基础上采用依达拉奉治疗。结果治疗7、14d,2组IL-1、IL-6、IL-8及TNF-α的水平有显著性差异,实验组IL-1、IL-6、IL-8及TNF-α的炎性因子的水平明显高于对照组(P<0.05)。治疗7、14d后,实验组NIHSS评分明显优于对照组(P<0.05),ADL评分明显高于对照组(P<0.01)。实验组总有效率(97.1%)明显高于对照组(76.5%),2组比较差异有统计学意义(χ2=14.2178,P=0.0026)。结论依达拉奉治疗脑出血疗效显著,可显著改善患者的炎性细胞因子水平。
目的:研究依達拉奉對急性腦齣血患者炎性細胞因子水平及神經功能的影響。方法68例腦齣血患者隨機均分為實驗組和對照組,對照組採用常規脫水藥、抗生素等治療,實驗組在對照組基礎上採用依達拉奉治療。結果治療7、14d,2組IL-1、IL-6、IL-8及TNF-α的水平有顯著性差異,實驗組IL-1、IL-6、IL-8及TNF-α的炎性因子的水平明顯高于對照組(P<0.05)。治療7、14d後,實驗組NIHSS評分明顯優于對照組(P<0.05),ADL評分明顯高于對照組(P<0.01)。實驗組總有效率(97.1%)明顯高于對照組(76.5%),2組比較差異有統計學意義(χ2=14.2178,P=0.0026)。結論依達拉奉治療腦齣血療效顯著,可顯著改善患者的炎性細胞因子水平。
목적:연구의체랍봉대급성뇌출혈환자염성세포인자수평급신경공능적영향。방법68례뇌출혈환자수궤균분위실험조화대조조,대조조채용상규탈수약、항생소등치료,실험조재대조조기출상채용의체랍봉치료。결과치료7、14d,2조IL-1、IL-6、IL-8급TNF-α적수평유현저성차이,실험조IL-1、IL-6、IL-8급TNF-α적염성인자적수평명현고우대조조(P<0.05)。치료7、14d후,실험조NIHSS평분명현우우대조조(P<0.05),ADL평분명현고우대조조(P<0.01)。실험조총유효솔(97.1%)명현고우대조조(76.5%),2조비교차이유통계학의의(χ2=14.2178,P=0.0026)。결론의체랍봉치료뇌출혈료효현저,가현저개선환자적염성세포인자수평。
Objective To study the effects of edaravone on the inflammatory cytokines and nerve function of patients with acute cerebral hemorrhage.Methods Sixty-eight cases with cerebral hemorrhage from March 2011 to March 2013 in our hospi-tal were studied and were randomly divided into experimental group and control group ,the control group were used with con-ventional dehydration drugs ,antibiotics ,the experimental group received edaravone based on the use of conventional thera-py.Results Before and after treatment ,comparative analysis of inflammatory cytokines of IL-1 ,IL-6 ,IL-8 and TNF-αlevels in patients of the two groups showed that on treatment of 7d ,14d ,the levels of IL-1 ,IL-6 ,IL-8 and TNF-αin patients of the two groups were significantly different ,the levels of IL-1 ,IL-6 ,IL-8 and TNF-α in patients of the experimental group were lower than those of the control group (P< 0.05).And the NIHSS scores were used to analyze the neurological damage of the two groups ,the result showed that after treatment of 7d ,14d ,the NIHSS scores of the experimental group score was significantly better than that of the control group(P<0.05).After treatment of 7d ,14d ,ADL score of the experimental group was signifi-cantly higher than that of the control group(P<0.01).After treatment ,the clinical efficacy of the two groups were compared and found that the total efficiency of experimental group (97.1% ) was significantly higher than that of the control group (76.5% ) ,the difference was statistically significant (χ2 =14.2178 ,P=0.0026).Conclusion Edaravone treatment for cerebral hemorrhage has a significant effectiveness and can significantly improve the patient's inflammatory cytokine levels.